These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31059035)

  • 1. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
    Li D; Lu J; Li H; Qi S; Yu L
    Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
    Gong Z; Hong F; Wang H; Zhang X; Chen J
    BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
    Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
    Jiang G; Dong H; Dong Y; Yang X
    Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
    Zhao J; Xu J; Shang AQ; Zhang R
    Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
    Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
    Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles.
    Liu Q; Qi C; Li G; Su W
    Biomed Res Int; 2019; 2019():5076467. PubMed ID: 31950039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
    Zhou M; Zhang Z; Zhao H; Bao S; Cheng L; Sun J
    Mol Neurobiol; 2018 May; 55(5):3684-3697. PubMed ID: 28527107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.